<?xml version="1.0" encoding="UTF-8"?>
<p id="par0260">There is evidence showing that variants in the 
 <italic>CCR5</italic> gene can influence multiple aspects of CMV infection (
 <xref rid="bib0945" ref-type="bibr">Loeffler et al., 2006</xref>; 
 <xref rid="bib1330" ref-type="bibr">Sezgin et al., 2011</xref>). For example, the 
 <italic>CCR5</italic> promoter polymorphism rs1800023 affects CMV replication (
 <xref rid="bib0165" ref-type="bibr">Bravo et al., 2014</xref>; 
 <xref rid="bib0295" ref-type="bibr">Corrales et al., 2015</xref>). In a study evaluating children, 
 <xref rid="bib0710" ref-type="bibr">Kasztelewicz et al. (2017)</xref> found no influence of CCR5Δ32 on susceptibility to congenital CMV infection, severity of congenital CMV disease, or CMV-related sensorineural hearing loss at birth. As an individual genetic factor, CCR5Δ32 was not statistically associated with the progression of CMV retinitis, a condition that CMV can cause in immunocompromised individuals (
 <xref rid="bib1330" ref-type="bibr">Sezgin et al., 2011</xref>) (
 <xref rid="tbl0030" ref-type="table">Table 6</xref>).
</p>
